TY - JOUR
T1 - Copy number variants suggest different molecular pathways for the pathogenesis of bladder exstrophy
AU - Nordenskjöld, Agneta
AU - Arkani, Samara
AU - Pettersson, Maria
AU - Winberg, Johanna
AU - Cao, Jia
AU - Fossum, Magdalena
AU - Anderberg, Magnus
AU - Barker, Gillian
AU - Holmdahl, Gundela
AU - Lundin, Johanna
N1 - © 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
PY - 2023/2
Y1 - 2023/2
N2 - Bladder exstrophy is a rare congenital malformation leaving the urinary bladder open in the midline of the abdomen at birth. There is a clear genetic background with chromosome aberrations, but so far, no consistent findings apart from 22q11-duplications detected in about 2%-3% of all patients. Some genes are implicated like the LZTR1, ISL1, CELSR3, and the WNT3 genes, but most are not explained molecularly. We have performed chromosomal microarray analysis on a cohort of 140 persons born with bladder exstrophy to look for submicroscopic chromosomal deletions and duplications. Pathogenic or possibly pathogenic microdeletions or duplications were found in 16 patients (11.4%) and further 9 with unknown significance. Two findings were in regions linked to known syndromes, two findings involved the same gene (MCC), and all other findings were unique. A closer analysis suggests a few gene networks that are involved in the pathogenesis of bladder exstrophy; the WNT-signaling pathway, the chromosome 22q11 region, the RIT2 and POU families, and involvement of the Golgi apparatus. Bladder exstrophy is a rare malformation and is reported to be associated with several chromosome aberrations. Our data suggest involvement of some specific molecular pathways.
AB - Bladder exstrophy is a rare congenital malformation leaving the urinary bladder open in the midline of the abdomen at birth. There is a clear genetic background with chromosome aberrations, but so far, no consistent findings apart from 22q11-duplications detected in about 2%-3% of all patients. Some genes are implicated like the LZTR1, ISL1, CELSR3, and the WNT3 genes, but most are not explained molecularly. We have performed chromosomal microarray analysis on a cohort of 140 persons born with bladder exstrophy to look for submicroscopic chromosomal deletions and duplications. Pathogenic or possibly pathogenic microdeletions or duplications were found in 16 patients (11.4%) and further 9 with unknown significance. Two findings were in regions linked to known syndromes, two findings involved the same gene (MCC), and all other findings were unique. A closer analysis suggests a few gene networks that are involved in the pathogenesis of bladder exstrophy; the WNT-signaling pathway, the chromosome 22q11 region, the RIT2 and POU families, and involvement of the Golgi apparatus. Bladder exstrophy is a rare malformation and is reported to be associated with several chromosome aberrations. Our data suggest involvement of some specific molecular pathways.
KW - Bladder Exstrophy/genetics
KW - Chromosome Aberrations
KW - Chromosomes
KW - DNA Copy Number Variations/genetics
KW - Humans
KW - Infant, Newborn
KW - Transcription Factors/genetics
KW - Urinary Bladder/abnormalities
KW - genetic
KW - bladder exstrophy
KW - CMA
KW - chromosome
UR - http://www.scopus.com/inward/record.url?scp=85141564972&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.63031
DO - 10.1002/ajmg.a.63031
M3 - Journal article
C2 - 36349425
SN - 1552-4825
VL - 191
SP - 378
EP - 390
JO - American Journal of Medical Genetics. Part A
JF - American Journal of Medical Genetics. Part A
IS - 2
ER -